Express Scripts Canada Announces Leadership Transition: Dr. Dorian Lo Retires, Mr. Michael Roszak promoted to President

Express Scripts Canada, Canada's leading pharmacy benefits manager, announces a significant leadership transition, as Dr. Dorian Lo, President, retires after more than five years of service. The organization is pleased to announce the promotion of Michael Roszak, an experienced leader in pharmacy benefits management, as his successor.

Dr. Dorian Lo leaves behind a legacy of visionary leadership and transformative initiatives. With more than twenty-five years of experience as a physician and business leader, Dr. Lo has been instrumental in shaping the strategic direction of Express Scripts Canada, fortifying its position as Canada's leading pharmacy benefits manager. His unwavering commitment to improving healthcare outcomes for Canadians has been the cornerstone of his tenure.

Reflecting on his time with ESC, Dr. Dorian Lo expressed his gratitude, by noting, "It has been an honor to lead the Express Scripts team and contribute to its growth and success. I am immensely proud of what we have accomplished together and am confident in the organization's continued success under Michael Roszak’s leadership."

Stepping into the role of President is Michael Roszak, an industry veteran with more than twenty-five years of experience in the pharmacy benefits management space. Michael has been ESC’s Chief Operating Officer for the last five years and holds an MBA from Queen’s University, and is a Chartered Professional Accountant. His dynamic leadership style and proven track record of accomplishments position him to lead Express Scripts Canada into its next phase of growth and innovation.

Michael Roszak commented on his appointment, stating, "I am honored to lead Express Scripts Canada and build upon the remarkable legacy established by Dr. Dorian Lo. I am committed to continuing the organization's mission of improving health outcomes for all Canadians."